Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002537752 | SCV003482742 | likely benign | not provided | 2024-12-03 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003166601 | SCV003889551 | uncertain significance | Inborn genetic diseases | 2023-01-11 | criteria provided, single submitter | clinical testing | The c.8569G>A (p.E2857K) alteration is located in exon 116 (coding exon 116) of the COL7A1 gene. This alteration results from a G to A substitution at nucleotide position 8569, causing the glutamic acid (E) at amino acid position 2857 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Natera, |
RCV001277577 | SCV001464537 | uncertain significance | Epidermolysis bullosa dystrophica inversa, autosomal recessive | 2020-10-28 | no assertion criteria provided | clinical testing |